The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Circulating Endothelial Microparticles Are Associated with Vascular Dysfunction in Patients with End-Stage Renal Failure
Abstract
Endothelial dysfunction and arterial stiffness are major determinants of cardiovascular risk in patients with end-stage renal failure (ESRF). Microparticles are membrane fragments shed from damaged or activated cells. Because microparticles can affect endothelial cells, this study investigated the relationship between circulating microparticles and arterial dysfunction in patients with ESRF and identified the cellular origin of microparticles associated with these alterations. Flow cytometry analysis of platelet-free plasma from 44 patients with ESRF indicated that circulating levels of Annexin V+ microparticles were increased compared with 32 healthy subjects, as were levels of microparticles derived from endothelial cells (three-fold), platelets (16.5-fold), and erythrocytes (1.6-fold). However, when arterial function was evaluated noninvasively in patients with ESRF, only endothelial microparticle levels correlated highly with loss of flow-mediated dilation (r = -0.543; P = 0.004), increased aortic pulse wave velocity (r = 0.642, P < 0.0001), and increased common carotid artery augmentation index (r = 0.463, P = 0.0017), whereas platelet-derived, erythrocyte-derived, and Annexin V+ microparticle levels did not. In vitro, microparticles from patients with ESRF impaired endothelium-dependent relaxations and cyclic guanosine monophosphate generation, whereas microparticles from healthy subjects did not. Moreover, in vitro endothelial dysfunction correlated with endothelial-derived (r = 0.891; P = 0.003) but not platelet-derived microparticle concentrations. In fact, endothelial microparticles alone decreased endothelial nitric oxide release by 59 +/- 7% (P = 0.025). This study suggests that circulating microparticles of endothelial origin are tightly associated with endothelial dysfunction and arterial dysfunction in ESRF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138
Self-citationAsmar, R., Benetos, A., Topouchian, J., Laurent, P., Pannier, B., Brisac, A.-M., Target, R., & Levy, B. I. (1995) · Hypertension · doi:10.1161/01.hyp.26.3.485 · Cited by 1,376
Combes, V., Simon, A.-C., Grau, G.-E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., & Dignat-George, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4985 · Cited by 732
Aortic pulse wave velocity index and mortality in end-stage renal disease
Blacher, J., Safar, M. E., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00932.x · Cited by 532
Self-citationCirculating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction
Boulanger, C. M., Scoazec, A., Ebrahimian, T., Henry, P., Mathieu, E., Tedgui, A., & Mallat, Z. (2001) · Circulation · doi:10.1161/hc4701.100516 · Cited by 510
Self-citationEffects of Severe Hypertension on Endothelial and Platelet Microparticles
Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., & Ahn, Y. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000049760.15764.2d · Cited by 499
Cardiac and arterial interactions in end-stage renal disease
London, G. M., Guerin, A. P., Marchais, S. J., Pannier, B., Safar, M. E., Day, M., & Metivier, F. (1996) · Kidney International · doi:10.1038/ki.1996.355 · Cited by 474
Self-citationHigh levels of circulating endothelial microparticles in patients with acute coronary syndromes
Bernal-Mizrachi, L., Jy, W., Jimenez, J. J., Pastor, J., Mauro, L. M., Horstman, L. L., de Marchena, E., & Ahn, Y. S. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00103-0 · Cited by 441
Cellular microparticles: what are they bad or good for?
Freyssinet, J.-M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00309.x · Cited by 399
Endothelium-derived microparticles impair endothelial function in vitro
Brodsky, S. V., Zhang, F., Nasjletti, A., & Goligorsky, M. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01172.2003 · Cited by 379
Cellular microparticles: new players in the field of vascular disease?
Diamant, M., Tushuizen, M. E., Sturk, A., & Nieuwland, R. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01355.x · Cited by 364
Diamant, M., Nieuwland, R., Pablo, R. F., Sturk, A., Smit, J. W. A., & Radder, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000036596.59665.c6 · Cited by 359
Arterial Stiffness and Kidney Function
Safar, M. E., London, G. M., & Plante, G. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000114571.75762.b0 · Cited by 325
Self-citationNitric Oxide and the Regulation of Large Artery Stiffness: From Physiology to Pharmacology
Wilkinson, I. B., Franklin, S. S., & Cockcroft, J. R. (2004) · Hypertension · doi:10.1161/01.hyp.0000138068.03893.40 · Cited by 272
Martin, S., Tesse, A., Hugel, B., Martínez, M. C., Morel, O., Freyssinet, J.-M., & Andriantsitohaina, R. (2004) · Circulation · doi:10.1161/01.cir.0000124065.31211.6e · Cited by 245
Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure
Wever, R., Boer, P., Hijmering, M., Stroes, E., Verhaar, M., Kastelein, J., Versluis, K., Lagerwerf, F., van Rijn, H., Koomans, H., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1168 · Cited by 219
Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors.
London, G. M., Marchais, S. J., Guérin, A. P., Métivier, F., & Pannier, B. (1993) · PubMed · Cited by 166
Self-citationCardiovascular risk in uraemic patients—is it fully explained by classical risk factors?
Zoccali, C. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.4.454 · Cited by 162
VanWijk, M. J., Nieuwland, R., Boer, K., van der Post, J., VanBavel, E., & Sturk, A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.124279 · Cited by 147
Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients
van Guldener, C. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1782 · Cited by 125
Endothelial dysfunction and inflammation: What is the link?
Galle, J., Quaschning, T., Seibold, S., & Wanner, C. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.12.x · Cited by 117
Myers, J., & Baker, P. N. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00705-1 · Cited by 104
Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Iwasaka, T., & Fukuhara, S. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000302 · Cited by 81
Azizi, M., Boutouyrie, P., Bissery, A., Agharazii, M., Verbeke, F., Stern, N., Bura-Rivière, A., Laurent, S., Alhenc‐Gelas, F., & Jeunemaı̂tre, X. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523669 · Cited by 80
Impairment of Vascular Responses to Reactive Hyperemia and Nitric Oxide in Chronic Renal Failure
Nakanishi, T., Ishigami, Y., Otaki, Y., Izumi, M., Hiraoka, K., Inoue, T., & Takamitsu, Y. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064078 · Cited by 18
Cited by
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
György, B., Szabó, T. G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., László, V., Pállinger, É., Pap, E., Kittel, Á., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0689-3 · Cited by 2,074
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., & Biancone, L. (2010) · Kidney International · doi:10.1038/ki.2010.278 · Cited by 1,178
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ramezani, A., & Raj, D. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 743
The Many Faces of Endothelial Microparticles
Dignat-George, F., & Boulanger, C. M. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.218123 · Cited by 635
Self-citation
Metadata
- Authors
- Amabile, N., Guérin, A. P., Leroyer, A., Mallat, Z., Nguyen, C., Boddaert, J., London, G. M., Tedgui, A., & Boulanger, C. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-11
- Volume
- 16
- Issue
- 11
- Pages
- 3381-3388
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2137742067
- Cited by
- 552
- References
- 28
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.